|
| 24808632 | Measuring the evolution and output of cross-disciplinary collaborations within the NCI Physical Sciences-Oncology Centers Network. | Res Eval | 2013 |
| 16409004 | Practical method for transforming alkynes into alpha-diketones. | J Org Chem | 2006 |
| 14522935 | The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model. | Cancer Res | 2003 |
| 9629471 | Synthesis and antiviral activity of prodrugs of the nucleoside 1-[2',3'-dideoxy-3'-C-(hydroxymethyl)-beta-D-erythropentofuranosyl] cytosine. | Bioorg Med Chem | 1998 |
| 9003514 | Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene. | J Med Chem | 1997 |
| 9391160 | Molecular determinants of tissue selectivity in estrogen receptor modulators. | Proc Natl Acad Sci U S A | 1997 |
| 8964828 | LY191704 inhibits type I steroid 5 alpha-reductase in human scalp. | J Clin Endocrinol Metab | 1996 |
| 7479389 | Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model. | Prostate | 1995 |
| 7811032 | Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers. | Antimicrob Agents Chemother | 1994 |
| 8141592 | The in vitro anti-hepatitis B virus activity of FIAU [1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell. | Antiviral Res | 1994 |
| 8234067 | Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat. | Prostate | 1993 |
| 8389478 | LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. | Proc Natl Acad Sci U S A | 1993 |
| 8381185 | Nonsteroidal inhibitors of human type I steroid 5-alpha-reductase. | J Med Chem | 1993 |
| 1548683 | Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogues of trioxifene, [3,4-dihydro-2-(4- methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]- phenyl]methanone. | J Med Chem | 1992 |
| 2296032 | Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups. | J Med Chem | 1990 |
| 2531383 | Antagonism of androgen and estrogen effects in guinea pig seminal vesicle epithelium and fibromuscular stroma by keoxifene (LY156758). | Prostate | 1989 |
| 3612685 | Aromatase inhibition by 5-substituted pyrimidines and dihydropyrimidines. | J Med Chem | 1987 |
| 3504060 | Discovery and development of a novel class of nonsteroidal aromatase inhibitors. | Steroids | 1987 |
| 6431104 | Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity. | J Med Chem | 1984 |
| 6406781 | Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels. | Life Sci | 1983 |
| 6827921 | Antagonism of estrogen action with a new benzothiophene derived antiestrogen. | Life Sci | 1983 |
| 7239000 | Differential interaction of antiestrogens with cytosol estrogen receptors. | Mol Cell Endocrinol | 1981 |
| 490541 | Synthesis and antiestrogenic activity of [3,4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]-phenyl]methanone, methanesulfonic acid salt. | J Med Chem | 1979 |